SlideServe
Menu
Préférences
© SlideServe · v2026

Analytical Method Development and Validation

EmileyWatsonn avatar
2 diapositives · 308 Views · Oct 11, 2019

Producing biosimilars is quite challenging as drug manufacturers face multiple bottlenecks while ensuring product quality and patient safety. Analytical method development and validation provides the data needed to manufacture safe and valuable drugs.

Analytical Method Development and Validation - slide 1
01 / 2Analytical Method Development and Validation
1 / 17

Télécharger la présentation

Analytical Method Development and Validation
Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation

Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement. Téléchargez la présentation en cliquant sur ce lien. Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.

F I N

Plus de contenu associé

Transcription de la présentation
  1. ANALYTICAL DEVELOPMENT Kemwell offers analytical services, analytical method development and method validation services for mammalian cell culture-based products to support your clinical and commercial product needs. Our efficient and strong Analytical Development team is unified into R&D services. Kemwell provides Development approach covers all aspects for intended use of the method (stability indicating, process development support, limits of detection/ quantitation, etc.) Extent of method validation studies are based on the stage of the product development and comply with the industry guidelines The analytical team in support of QC establishes reference standards based on regulatory requirements thorough characterization and comparability establishment. The reference standards are then stored under cGMP conditions. KEY EQUIPMENT LIST •Lab-scale lyophilizer •HPLC and UPLC systems •Capillary electrophoresis •Micro-plate reader (UV-Vis, Absorbance, Fluorescence) •Spectrophotometer ANALYTICAL DEVELOPMENT 1/2

  2. Analytical method development and optimization for various assays including: Process related impurities & identity Protein related impurities and variants Invitro Bioassays Miscellaneous •CHO HCP quantification -ELISA •Residual DNA determination •Q-PCR & Pico-Green method •Protein A contaminant qualification by ELISA •Mycoplasma by RT-PCR •BET test •Kinetic chromogenic lysate assay •Gel clot assay •Identity •Peptide mapping •Immuno blotting •Electrophoretic techniques •Charged variant by CEX & cIEF •Size related impurities by SEC, SDS-PAGE (NR) & CE-SDS (NR) •Degraded protein by-SDS-PAGE, CE-SDS (NR) •Oxidised and reduced impurities by RP-HPLC •IgG purity- quantification of free heavy chain and light chain, non- glycosylated IgG, Intact IgG and other fragmented species by Capillary Electrophoresis •Isoform variants by IEF, CZE and IEF with western blotting •Glycan profiling by Capillary Electrophoresis and UPLC •Cell proliferation assays •Anti-proliferation assays •CDC Complement Dependent Cytotoxicity) assays •Cell based cAMP release assay •Binding assays •Reporter gene assay •Compendial methods for parenteral i.e. Sterlity, Endotoxin, Visible and sub-visible particulate matter, Degree of coloration and opalescence •Content assays by absorbance, Colorimetric and HPLC based methods •Raw material analysis including moisture content, melting point, refractive index, FTIR and various identity and assay methods * outsourced to a partner & managed by Kemwell CONTACT US Bangalore, India +91 80 2698 2400 www.kemwellbiopharma.com ANALYTICAL DEVELOPMENT 2/2